TNFSF10 and metastatic neoplasm: Furthermore, it was found that the antimetastatic influences of MSC-TRAIL-TK were enriched through serial injections but not via augmented dose, offering an attractive therapeutic tactic to eliminate metastatic tumors by repeated injection of MSC-TRAIL-TK (Kim et al., 2013).